• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯高血糖不会增加1型糖尿病男性极低密度脂蛋白三酰甘油的分泌。

Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men.

作者信息

Johansen Rakel F, Søndergaard Esben, Sørensen Lars Peter, Nellemann Birgitte, Christiansen Jens S, Nielsen Søren

机构信息

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus C, Denmark,

出版信息

Diabetologia. 2015 Feb;58(2):355-62. doi: 10.1007/s00125-014-3422-6. Epub 2014 Nov 11.

DOI:10.1007/s00125-014-3422-6
PMID:25385409
Abstract

AIMS/HYPOTHESIS: In type 1 diabetes, abnormalities of both glucose and lipoprotein metabolism are seen. The relationship between these factors is not understood, but studies indicate that hyperglycaemia may increase hepatic VLDL-triacylglycerol (VLDL-TG) secretion and reduce VLDL-TG fatty acid oxidation, which could lead to the development of dyslipidaemia. The aim of this study was to determine the isolated effect of hyperglycaemia on VLDL-TG and NEFA kinetics in men with type 1 diabetes.

METHODS

VLDL-TG and palmitate kinetics were measured in eight men with type 1 diabetes using ex vivo labelled VLDL-TG and palmitate tracers. A 2.5 h basal period (plasma glucose 5 mmol/l) was followed by a 4 h hyperglycaemic period (plasma glucose 16 mmol/l). Steady-state VLDL-TG kinetics (VLDL-TG secretion, clearance and oxidation rates) were assessed by an isotope dilution technique using an intravenous primed-constant infusion of ex vivo labelled [1-(14)C]VLDL-TG in combination with sampling of blood and expired air. Palmitate turnover was measured using [9,10-(3)H]palmitate.

RESULTS

The VLDL-TG secretion rate (36.0 ± 9.6 vs 30.8 ± 6.1 μmol/min, NS) and clearance rate (209 ± 30.4 vs 197 ± 41.7 ml/min, NS) were unchanged during the basal and hyperglycaemic periods, resulting in unchanged VLDL-TG concentrations (0.25 ± 0.11 μmol/l vs 0.28 ± 0.10 μmol/l, NS). In addition, VLDL-TG fatty acid oxidation and palmitate flux were not changed during hyperglycaemia.

CONCLUSIONS/INTERPRETATION: Four hours of acute hyperglycaemia (16 mmol/l) without a concomitant increase in insulin does not alter VLDL-TG and NEFA kinetics in men with type 1 diabetes.

CLINICAL TRIAL REGISTRY NUMBER

NCT01178957.

摘要

目的/假设:在1型糖尿病中,可见葡萄糖和脂蛋白代谢均异常。这些因素之间的关系尚不清楚,但研究表明,高血糖可能会增加肝脏极低密度脂蛋白三酰甘油(VLDL-TG)的分泌,并降低VLDL-TG脂肪酸氧化,这可能导致血脂异常的发生。本研究的目的是确定高血糖对1型糖尿病男性患者VLDL-TG和非酯化脂肪酸(NEFA)动力学的单独影响。

方法

使用体外标记的VLDL-TG和棕榈酸示踪剂,对8名1型糖尿病男性患者的VLDL-TG和棕榈酸动力学进行测量。先进行2.5小时的基础期(血浆葡萄糖5 mmol/l),随后是4小时的高血糖期(血浆葡萄糖16 mmol/l)。通过同位素稀释技术,静脉注射体外标记的[1-(14)C]VLDL-TG并结合采血和收集呼出气体,评估稳态VLDL-TG动力学(VLDL-TG分泌、清除和氧化率)。使用[9,10-(3)H]棕榈酸测量棕榈酸周转率。

结果

基础期和高血糖期的VLDL-TG分泌率(36.0±9.6对30.8±6.1 μmol/min,无显著差异)和清除率(209±30.4对197±41.7 ml/min,无显著差异)均未改变,导致VLDL-TG浓度不变(0.25±0.11 μmol/l对0.28±0.10 μmol/l,无显著差异)。此外,高血糖期间VLDL-TG脂肪酸氧化和棕榈酸通量未发生变化。

结论/解读:4小时急性高血糖(16 mmol/l)且胰岛素未随之增加,不会改变1型糖尿病男性患者的VLDL-TG和NEFA动力学。

临床试验注册号

NCT01178957。

相似文献

1
Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men.单纯高血糖不会增加1型糖尿病男性极低密度脂蛋白三酰甘油的分泌。
Diabetologia. 2015 Feb;58(2):355-62. doi: 10.1007/s00125-014-3422-6. Epub 2014 Nov 11.
2
Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.与甘精胰岛素相比,在 1 型糖尿病患者中,聚乙二醇化赖脯胰岛素治疗导致基础胰岛素抑制脂肪分解作用减弱,从而引起甘油三酯分泌和浓度增加。
Diabetes Obes Metab. 2018 Feb;20(2):419-426. doi: 10.1111/dom.13087. Epub 2017 Oct 10.
3
Postprandial VLDL-triacylglycerol secretion is not suppressed in obese type 2 diabetic men.餐后 VLDL-三酰甘油分泌在肥胖 2 型糖尿病男性中未受抑制。
Diabetologia. 2012 Oct;55(10):2733-2740. doi: 10.1007/s00125-012-2624-z. Epub 2012 Jun 30.
4
Alterations in lipid kinetics in men with HIV-dyslipidemia.HIV相关性血脂异常男性的脂质动力学改变
Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E490-7. doi: 10.1152/ajpendo.00118.2003. Epub 2003 May 13.
5
Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.2型糖尿病男性患者中基础及胰岛素调节的极低密度脂蛋白1(VLDL1)和极低密度脂蛋白2(VLDL2)动力学
Diabetologia. 2016 Apr;59(4):833-43. doi: 10.1007/s00125-015-3856-5. Epub 2016 Jan 19.
6
Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion.高血糖诱导的内脏脂肪酸氧化抑制增加肝脏三酰甘油分泌。
Am J Physiol. 1998 Nov;275(5):E798-805. doi: 10.1152/ajpendo.1998.275.5.E798.
7
Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men.2 型糖尿病男性的基础状态和胰岛素介导的 VLDL-甘油三酯动力学。
Diabetes. 2011 Jan;60(1):88-96. doi: 10.2337/db10-0564. Epub 2010 Sep 21.
8
Ten weeks of aerobic training does not result in persistent changes in VLDL triglyceride turnover or oxidation in healthy men.10 周的有氧运动训练不会导致健康男性的 VLDL 甘油三酯周转率或氧化持续改变。
Eur J Endocrinol. 2014 Nov;171(5):603-13. doi: 10.1530/EJE-14-0333. Epub 2014 Aug 12.
9
Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease.非酒精性脂肪肝中胰岛素对 VLDL-甘油三酯动力学的抑制作用受损。
J Clin Endocrinol Metab. 2016 Apr;101(4):1637-46. doi: 10.1210/jc.2015-3476. Epub 2016 Feb 1.
10
No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.白藜芦醇对非酒精性脂肪性肝病肥胖男性患者 VLDL-TG 动力学和胰岛素敏感性无影响。
Diabetes Obes Metab. 2018 Oct;20(10):2504-2509. doi: 10.1111/dom.13409. Epub 2018 Jul 5.

本文引用的文献

1
Is the risk and nature of CVD the same in type 1 and type 2 diabetes?1 型和 2 型糖尿病的 CVD 风险和性质是否相同?
Curr Diab Rep. 2013 Jun;13(3):350-61. doi: 10.1007/s11892-013-0380-1.
2
Postprandial VLDL-triacylglycerol secretion is not suppressed in obese type 2 diabetic men.餐后 VLDL-三酰甘油分泌在肥胖 2 型糖尿病男性中未受抑制。
Diabetologia. 2012 Oct;55(10):2733-2740. doi: 10.1007/s00125-012-2624-z. Epub 2012 Jun 30.
3
Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication.
1 型糖尿病成人的血糖与血脂的相关性:血脂异常药物治疗的影响。
Diabetologia. 2010 Dec;53(12):2518-25. doi: 10.1007/s00125-010-1886-6. Epub 2010 Sep 4.
4
Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein.FoxO1 失活障碍导致葡萄糖介导的血清极低密度脂蛋白增加。
Endocrinology. 2010 Aug;151(8):3566-76. doi: 10.1210/en.2010-0204. Epub 2010 May 25.
5
Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding.高碳水化合物喂养3天后,从头脂肪生成和硬脂酰辅酶A去饱和酶活性的平行激活。
Am J Clin Nutr. 2008 Apr;87(4):817-23. doi: 10.1093/ajcn/87.4.817.
6
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment.因血糖浓度高于最佳水平导致的缺血性心脏病和中风的全球及区域死亡率:比较风险评估
Lancet. 2006 Nov 11;368(9548):1651-9. doi: 10.1016/S0140-6736(06)69700-6.
7
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.1型糖尿病患者的强化糖尿病治疗与心血管疾病
N Engl J Med. 2005 Dec 22;353(25):2643-53. doi: 10.1056/NEJMoa052187.
8
Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer.使用体外制备的极低密度脂蛋白(VLDL)示踪剂测量人体中极低密度脂蛋白甘油三酯的周转率。
J Lipid Res. 2006 Jan;47(1):99-106. doi: 10.1194/jlr.M500205-JLR200. Epub 2005 Oct 18.
9
Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.糖化血红蛋白A1c与成人心血管疾病及死亡率的关联:诺福克欧洲癌症前瞻性调查研究
Ann Intern Med. 2004 Sep 21;141(6):413-20. doi: 10.7326/0003-4819-141-6-200409210-00006.
10
Diabetic dyslipidaemia: from basic research to clinical practice.糖尿病血脂异常:从基础研究到临床实践
Diabetologia. 2003 Jun;46(6):733-49. doi: 10.1007/s00125-003-1111-y. Epub 2003 May 28.